Hester Biosciences Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 5 October 2026, 8:48 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price2,106₹ per share
Reported P/E33.5Times
Book value per share423₹ per share
Reported ROCE15.2 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 5 October 2026, 8:48 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap1,780 Cr.
Current Price2,106
High / Low2,684/1,239
Stock P/E33.5
Book Value423
Dividend Yield0.52 %
ROCE15.2 %
ROE15.9 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Hester Biosciences Ltd 1,780 Cr. 2,106 2,684/1,23933.5 4230.52 %15.2 %15.9 % 10.0
Fermenta Biotech Ltd 1,628 Cr. 553 580/24929.8 1380.68 %20.6 %16.4 % 5.00
Jagsonpal Pharmaceuticals Ltd 1,528 Cr. 232 265/15532.5 41.21.73 %22.7 %17.3 % 2.00
Amrutanjan Health Care Ltd 1,496 Cr. 518 760/47624.0 1280.95 %24.8 %18.4 % 1.00
TTK Healthcare Ltd 1,431 Cr. 1,013 1,250/73518.7 7890.99 %8.04 %6.30 % 10.0
Industry Average17,523.99 Cr1,246.1054.94211.240.39%26.16%16.59%6.06

All Competitor Stocks of Hester Biosciences Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 887067798284638284717710077
Expenses 73575763656558636159606654
Operating Profit 1413101618195192312183423
OPM % 16%19%15%20%21%23%8%23%27%17%23%34%29%
Other Income 3625239-63122289
Interest 382756-4622253
Depreciation 5444444444467
Profit before tax 97610111213420171425102
Tax % 25%40%37%35%29%29%15%59%14%16%31%34%5%
Net Profit 744678112171491797
EPS in Rs 6.904.814.685.827.459.6413.711.5219.3316.9910.3118.78114.00

Last Updated: September 29, 2026, 8:36 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 27, 2026, 3:42 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 6990101123136178183214235266305311333326
Expenses 4464678289110128146175215251250246239
Operating Profit 2425344147685569605154628787
OPM % 36%28%34%33%35%38%30%32%26%19%18%20%26%27%
Other Income 13103761142015819105
Interest 654447774920131112
Depreciation 566710121313172117171922
Profit before tax 13182531365741505440324076157
Tax % 31%26%23%26%36%28%25%31%26%30%34%27%24%
Net Profit 9131923234131353928212957137
EPS in Rs 11.1115.9922.5727.6830.1248.8734.2940.4746.2231.3022.2132.3165.41160.08
Dividend Payout % 18%19%18%19%33%23%19%25%22%26%27%22%17%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)44.44%46.15%21.05%0.00%78.26%-24.39%12.90%11.43%-28.21%-25.00%38.10%96.55%
Change in YoY Net Profit Growth (%)0.00%1.71%-25.10%-21.05%78.26%-102.65%37.29%-1.47%-39.63%3.21%63.10%58.46%

Hester Biosciences Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:13%
5 Years:11%
3 Years:10%
TTM:5%
Compounded Profit Growth
10 Years:9%
5 Years:-1%
3 Years:-11%
TTM:94%
Stock Price CAGR
10 Years:14%
5 Years:6%
3 Years:0%
1 Year:-15%
Return on Equity
10 Years:14%
5 Years:11%
3 Years:9%
Last Year:9%

Last Updated: September 5, 2025, 6:05 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 30, 2026, 8:39 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 999999999999
Reserves 7693113132169193220251271283306352
Borrowings 5559666990121105228274244213195
Other Liabilities 2025253532657874116126126123
Total Liabilities 160186213244299387411562670662653678
Fixed Assets 6065102110145143133237259240233411
CWIP 33362132774109821491711839
Investments 00000002125303443
Other Assets 688589102148170169222237221203215
Total Assets 160186213244299387411562670662653678
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 20193538473758924486564
Cash from Investing Activity + -21-13-30-26-21-73-42-117-77-22-20-18
Cash from Financing Activity + 7-72-11319-1811242-26-52-49
Net Cash Flow 5-16128-17-23-12-0-7-3
Free Cash Flow 1551524-3617-87-54244447
CFO/OP 100%74%102%100%92%86%105%43%63%112%123%90%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow1.005.005.0015.0024.00-36.0017.00-87.00-54.0024.0044.0047.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 75729579876711684861099486
Inventory Days 1,145431627376505540834452424399288291
Days Payable 14568109841009326120410114198122
Cash Conversion Cycle 1,074434614371491514690332409367284255
Working Capital Days 367611290821061041341138811274
ROCE %18%15%19%19%20%26%16%18%14%9%9%10%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 53.73%53.73%53.73%53.73%53.73%53.73%53.73%53.73%53.73%53.73%53.73%53.73%
FIIs 0.42%0.43%0.43%0.52%0.61%0.59%0.87%0.51%0.53%0.52%0.38%0.31%
DIIs 0.00%0.00%0.00%0.00%0.00%0.02%0.02%0.02%0.00%0.01%0.00%0.00%
Public 45.84%45.83%45.84%45.74%45.66%45.65%45.38%45.73%45.73%45.75%45.88%45.95%
No. of Shareholders 13,34213,45012,84411,30511,53811,47311,85311,81012,26012,60312,37311,961
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal S&P BSE Healthcare ETF 41 0.08 0.01412025-04-22 17:25:330%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 33.8924.8832.9646.4140.79
Diluted EPS (Rs.) 33.8924.8832.9646.4140.79
Cash EPS (Rs.) 48.8239.6552.1065.4156.44
Book Value[Excl.RevalReserv]/Share (Rs.) 369.41356.03339.19314.32277.37
Book Value[Incl.RevalReserv]/Share (Rs.) 369.41356.03339.19314.32277.37
Revenue From Operations / Share (Rs.) 365.70357.99312.79276.25251.95
PBDIT / Share (Rs.) 76.3875.5877.3086.6686.21
PBIT / Share (Rs.) 56.6355.3952.9767.1770.56
PBT / Share (Rs.) 41.7032.1442.0262.3958.90
Net Profit / Share (Rs.) 29.0719.4627.7745.9240.79
NP After MI And SOA / Share (Rs.) 32.3122.2031.3046.4140.47
PBDIT Margin (%) 20.8821.1124.7131.3734.21
PBIT Margin (%) 15.4815.4716.9324.3128.00
PBT Margin (%) 11.408.9713.4322.5823.37
Net Profit Margin (%) 7.945.438.8716.6216.18
NP After MI And SOA Margin (%) 8.836.2010.0016.8016.06
Return on Networth / Equity (%) 8.746.479.5115.1815.08
Return on Capital Employeed (%) 9.128.468.6412.2817.16
Return On Assets (%) 4.202.853.977.028.37
Long Term Debt / Equity (X) 0.420.620.660.630.36
Total Debt / Equity (X) 0.660.810.950.850.37
Asset Turnover Ratio (%) 0.470.450.430.520.62
Current Ratio (X) 1.562.031.532.012.63
Quick Ratio (X) 0.991.310.961.231.62
Inventory Turnover Ratio (X) 4.260.670.660.520.39
Dividend Payout Ratio (NP) (%) 18.5636.0231.9421.5416.30
Dividend Payout Ratio (CP) (%) 11.5218.8617.9715.1711.76
Earning Retention Ratio (%) 81.4463.9868.0678.4683.70
Cash Earning Retention Ratio (%) 88.4881.1482.0384.8388.24
Interest Coverage Ratio (X) 5.123.257.0618.1411.11
Interest Coverage Ratio (Post Tax) (X) 2.951.843.5310.616.76
Enterprise Value (Cr.) 1279.651416.651555.602514.681703.08
EV / Net Operating Revenue (X) 4.114.655.8510.707.95
EV / EBITDA (X) 19.6922.0323.6634.1123.22
MarketCap / Net Operating Revenue (X) 3.433.884.869.837.61
Retention Ratios (%) 81.4363.9768.0578.4583.69
Price / BV (X) 3.394.054.628.887.14
Price / Net Operating Revenue (X) 3.433.884.869.837.61
EarningsYield 0.020.010.020.010.02
Advertisements